SCHEMBL6284205

SCHEMBL6284205

CCCc1ccc(CCCO)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 5/20 0.52
LIPG Q9Y5X9 5/20 0.52
CYP4A11 Q02928 2/20 0.52
ALDH1A1 P00352 3/20 0.50
ESR1 P03372 2/20 0.50
ADRA2A P08913 2/20 0.50
ADORA3 P0DMS8 2/20 0.50
TACR2 P21452 2/20 0.50
SLC6A2 P23975 2/20 0.50
SLC6A4 P31645 2/20 0.50
SLC6A3 Q01959 2/20 0.50
CA2 P00918 2/20 0.50
HSD17B10 Q99714 2/20 0.50
KDM4E B2RXH2 1/20 0.50
LMNA P02545 1/20 0.50
SHBG P04278 1/20 0.50
TP53 P04637 1/20 0.50
CYP3A4 P08684 1/20 0.50
HSPD1 P10809 1/20 0.50
ADRB3 P13945 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11894717 0.93 RARB (0.52) LPLLIPGCYP4A11ALDH1A1ESR1
SCHEMBL27641639 0.93 ESR1 (0.54) LPLLIPGCYP4A11ALDH1A1ESR1
SCHEMBL3031498 0.90 CA2 (0.59) LPLLIPGCYP4A11ALDH1A1ESR1
SCHEMBL6287871 0.88 ALDH1A1 (0.65) LPLLIPGALDH1A1ESR1ADRA2A
SCHEMBL239040 0.87 CA2 (0.60) CYP4A11ALDH1A1ESR1ADRA2AADORA3
SCHEMBL6282873 0.86 ESR1 (0.69) LPLLIPGALDH1A1ESR1ADRA2A
SCHEMBL6285688 0.86 ESR1 (0.69) LPLLIPGALDH1A1ESR1ADRA2A
SCHEMBL2726293 0.86 ESR1 (0.69) LPLLIPGALDH1A1ESR1ADRA2A
SCHEMBL79488 0.85 CYP4A11 (0.57) LPLLIPGCYP4A11ALDH1A1ESR1
SCHEMBL7643947 0.84 CA2 (0.59) LPLLIPGCYP4A11ALDH1A1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109690361-A Optical component forms composition 三菱瓦斯化学株式会社 2019-04-26 CN disclosed
CN-107533290-A RESIST BASE MATERIAL, RESIST COMPOSITION, AND METHOD FOR FORMING RESIST PATTERN 三菱瓦斯化学株式会社 2018-01-02 CN disclosed
CN-107407874-A Radiation-sensitive composition, amorphous film and corrosion-resisting pattern forming method 三菱瓦斯化学株式会社 2017-11-28 CN disclosed
CN-106957217-A Polyphenol compound for anti-corrosion agent composition 三菱瓦斯化学株式会社 2017-07-18 CN disclosed
US-8580146-B2 Liquid crystal compound, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2013-11-12 US disclosed
US-8580146-B2 Liquid crystal compound, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2013-11-12 US disclosed
US-8580146-B2 Liquid crystal compound, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2013-11-12 US disclosed
WO-2012150220-A1 RADIOLABELED AMINO ACIDS FOR DIAGNOSTIC IMAGING BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-11-08 WO disclosed
US-20120193577-A1 LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC PETROCHEMICAL CORPORATION (JP) 2012-08-02 US disclosed
US-20120193577-A1 LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC PETROCHEMICAL CORPORATION (JP) 2012-08-02 US disclosed
CN-1097074-C Thermoplastic resin composition DAICEL CHEM (JP) 2002-12-25 CN disclosed
CN-1357027-A Flameproof extrudates and flameproof mouldings produced by compression moulding BAYER AG (DE) 2002-07-03 CN disclosed
CN-1247740-A Water solution composition containing sulfonated polyester mixture OREAL (FR) 2000-03-22 CN disclosed
CN-1206027-A Thermoplastic resin composition DAICEL CHEM (JP) 1999-01-27 CN disclosed
CN-1203246-A Thermoplastic resin composition DAICEL CHEM (JP) 1998-12-30 CN disclosed
CN-1170015-A Thermoplastic resin composition DAICEL CHEM (JP) 1998-01-14 CN disclosed
EP-0513761-A2 Bisphosphonate squalene synthetase inhibitors E.R. SQUIBB & SONS, INC. (US) 1992-11-19 EP disclosed
US-5157027-A Anticholesterol agents E. R. SQUIBB & SONS, INC. (US) 1992-10-20 US disclosed
US-5116858-A Learning enhancement MITSUBISHI KASEI CORPORATION (JP) 1992-05-26 US disclosed
EP-0396973-A1 4-Imidazoline derivatives and their use in preparing pharmaceutical compositions MITSUBISHI KASEI CORPORATION (JP) 1990-11-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120193577-A1 LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE KIF23, MARK3, CCND3 LPL 3496/4885LIPG 3010/4885CYP4A11 2867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.